The mass spectrometry proteomics data have been deposited to the ProteomeXchange Consortium via the PRIDE partner repository with the dataset identifier PXD006466 and [10.6019/PXD006466](https://doi.org/10.6019/PXD006466).

Introduction {#sec001}
============

The supraspinatus tendon is part of the four rotator cuff tendons acting to stabilize the shoulder. The tendon proper is a viscoelastic and highly hierarchical tissue with collagen as the primary component of the extracellular matrix (ECM), organised in fibrils and fascicles surrounded by proteoglycan rich material \[[@pone.0177656.ref001]\]. Collagen is thought to account for 65--80% and the fibrous protein elastin for approximately 1--2% of the dry mass of tendon in general \[[@pone.0177656.ref002]\], with the latter described to occur in elastic fibres approximately 0.3--2.0*μ*m in diameter, broadly distributed throughout the tendon, localized longitudinally along cell arrays and between collagen fascicles \[[@pone.0177656.ref003]\]. The supraspinatus tendon is known to be poorly vascularised \[[@pone.0177656.ref004]\], with cell arrays embedded in a Collagen VI rich pericellular matrix \[[@pone.0177656.ref005]\]. Tears of this tendon are very common and are often painful and debilitating. The management of rotator cuff disease represent an increasing social and economic burden \[[@pone.0177656.ref006], [@pone.0177656.ref007]\]. The progression of rotator cuff disease is accompanied by numerous pathological changes \[[@pone.0177656.ref008]\], and various studies have sought to understand these by measuring differences between healthy and torn supraspinatus tendons. Past investigations have revealed changes in gene expression \[[@pone.0177656.ref009]\], ultrastructure \[[@pone.0177656.ref010]\] and the presence of specific biochemical markers \[[@pone.0177656.ref011]\]. Moreover, studies quantifying pre-specified mRNA molecules and proteins have shown collagen I and III, MMP-1, -3, -9, and -13, TIMP-1, and VEGF to be differentially abundant in human tendinopathy, but the link to rotator cuff tears remains uncertain \[[@pone.0177656.ref012]\]. To date, no studies using non-targeted, label-free protein quantitation to evaluate differential abundance of proteins between torn and healthy human rotator cuff supraspinatus tissue have been reported. The potential advantages of a non-targeted proteomics approach is the generation of a more complete inventory of proteins present in the tissue, the ability to quantitatively compare their abundance in the sample pool, and the possibility to identify proteins that display a significant fold-change and a biological likelihood of being candidate biomarkers. In here, grain-size biopsies of the supraspinatus tendon were homogenised and entirely digested by trypsin, with a parallel elastase digestion used as a validation and to complement and improve the proteome. This study reports the first ECM inventory of human supraspinatus tendon in health and disease, generated employing a label-free LC-MS/MS analysis.

Materials and methods {#sec002}
=====================

Donors and biopsies {#sec003}
-------------------

The 27 patients who donated tissue for the study were treated either for a shoulder stabilisation in which there is no tendon abnormality or a tendon tear (see [Table 1](#pone.0177656.t001){ref-type="table"}). Torn samples were obtained from patients with established tendon disease, presenting pain, full-thickness rotator cuff tears and scheduled to undergo surgery. Donated tissue were rice-grain sized end of biopsies, of around 2x1mm, collected using a minimally invasive ultrasound guided technique as previously described \[[@pone.0177656.ref013]\]. Tissue biopsies acquired using the same procedure were previously characterised by histological examination in several studies, demonstrating that diseased supraspinatus tissue was accurately collected \[[@pone.0177656.ref011], [@pone.0177656.ref014], [@pone.0177656.ref015]\]. After removal, biopsies were placed in 0.5ml Eppendorf tubes, snap-frozen in liquid nitrogen and stored at −80°C. Approval for the study was obtained from the Oxfordshire Research Ethics Committee (REC-B). All methods (tissue collection and storage) were performed in accordance with the relevant guidelines and regulations of the Oxford Musculoskeletal BioBank (OMB, ethics ref: 09/H606/11). All patients gave informed consent prior to tissue donation.

10.1371/journal.pone.0177656.t001

###### Demographics of tendon donors.
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  Group                         No of patients   Sex      Mean Age(SD)
  ----------------------------- ---------------- -------- --------------
  Male Control, normal tendon   9                Male     24.44 (2.62)
  Female torn tendon            9                Female   57.44 (8.7)
  Male torn tendon              9                Male     58.3 (8.4)

Protein extraction and digestion from tendon tissue {#sec004}
---------------------------------------------------

Rice-grain sized tendon tissue biopsies, approximately 1x2mm in size, were rinsed with cold phosphate buffered saline to remove residual blood proteins, transferred to screw-cap vials (M-tubes, Miltenyi Biotec) and suspended in 1.5 ml of strong chaotropic solution for 2 hours at room ambience (4M GuHCl, 10mM EDTA, 10mM DTT, 44mM sodium acetate). To homogenise the tissue biopsies, samples were vortexed and processed using the gentleMacs dissociator (Miltenyi Biotec), an automated tissue homogeniser. Thereafter, samples were centrifuged at a low speed for 5 minutes to collect dissociated tissue from the rotor/stator cup of the tube. The homogenisation procedure was repeated twice. Tubes were briefly vortexed and 0.5ml of each sample was transferred to a low-binding microcentrifuge tube and centrifuged for 10min at 14,000xg and 4°C. Protein material was then precipitated using Methanol/Chloroform \[[@pone.0177656.ref016]\]. Resulting protein pellets were re-suspended in 100*μ*l 6 M Urea in 100 mM Tris, pH 7.8. Following reduction with 10 mM DTT, cysteine residues were alkylated using a final concentration of 40 mM iodoacetamide for 30 min at room temperature. Samples were diluted with water to a final urea concentration of 0.67 M, and either trypsin (0.66ug/sample) or elastase (1ug/sample) were added. Digestion was carried out at 37°C overnight, after which samples were observed to be completely solubilised. Following acidification with formic acid (0.1% final concentration), obtained peptides were purified on a C18 reverse phase column (SepPak, Waters), dried and re-suspended in 20*μ*l 2% acetonitrile, 0.1% formic acid in water.

Label-free liquid-chromatography mass spectrometric analysis {#sec005}
------------------------------------------------------------

Each biological sample was analysed in duplicates. In order to make sure equivalent amounts of protein were analysed from each sample, total ion counts (TIC) was calculated using scout runs, and values were used to adjust the injection volume for the analytical sample runs. Equal amounts of peptide material were analysed by UPLC (nano Acquity, Waters) online coupled to an LTQ Orbitrap Elite (Thermo Scientific) as described previously \[[@pone.0177656.ref017]\]. Peptides were eluted by applying a 60 min linear gradient from 3% buffer A (0.1% formic acid in water) to 40% buffer B (0.1% formic acid in acetonitrile) on a 25 cm BEH130 C18 column, 1.7-mm particle size (Waters). Collision-induced dissociation (CID) was induced on the twenty most abundant ions per full MS scan.

Database searches and quantitative proteome analysis {#sec006}
----------------------------------------------------

All mass spectra of label-free samples were extracted by Progenesis LC-MS, and then analysed by Mascot (Matrix Science), which was set up to search against all human Swiss Prot database entries with the following parameters: Trypsin or no enzyme search for trypsin and elastase samples, respectively; fixed modification: carbamidomethylation (cysteine), variable modifications: Oxidation (proline, lysine) and allysine (lysine). Normalization between samples was achieved using the total ion intensities (TIC) of each individual sample. Criteria to ensure accurate identification of tendon proteins included a minimum of 2 peptides per protein and a confidence score cut-off of 20. One-way ANOVA was used to calculate the p-value based on the normalized abundance, and a Tukey post-test was performed, providing an adjusted P value to account for multiple comparisons. An adjusted ANOVA score of at least 0.05 between experimental groups was used to identify proteins significantly modulated in torn tendon. Proteins were grouped based on their protein class using the PANTHER database of protein families (version 10) and the Matrisome project, and protein interactions were identified using STRING version 10.0.

Independent verification of COMP by western blot {#sec007}
------------------------------------------------

In order to confirm the alteration in COMP expression, as identified by label-free mass spectrometry, immunoblot analysis was employed. Electrophoretic separation of proteins from the extracts pre enzymatic digestion was performed using gradient polyacrylamide gels (Criterion XT Pre-cast 4--12% Bis-Tris gel, 26 well) and a prestained molecular weight marker (Precision Plus Protein Standard All Blue, Biorad) followed by wet transfer at 100 V for 70 min at 4°/C to Immobilon-P PVDF membrane (Millipore, Billerica, USA) in a Transblot Cell from Bio-Rad Laboratories (Hemel-Hempstead, Hertfordshire, UK). Membranes were blocked for 1 hour at room temperature with Rotiblock (Carl-Roth, Karlsruhe, Germany) prior to incubation with the primary antibody (anti-COMP, ab74524, abcam UK) at a dilution of 1:1000 in Rotiblock, overnight at 4°C with gentle agitation. Membranes were subsequently washed twice with PBS containing 0.05% Tween 10 min each time, followed by incubation for 1 h with polyclonal horseradish peroxidase-conjugated goat-anti-mouse secondary antibody (P0447, Dako, Ely, UK) at a dilution of 1:10,000 in Rotiblock. Visualisation of antibody-labelled protein bands on washed membranes was achieved using Amersham ECL Prime Western Blotting Detection Reagent (GE Healthcare, UK) according to the manufacturer's guidelines.

Results {#sec008}
=======

Samples analysed in this study consisted of tendon supraspinatus biopsies from 27 donors belonging to three groups: aged and torn male donors (n = 9), aged and torn female donors (n = 9), and healthy and young male donors (n = 9), the later used as control. Significant differences in key tendon structural components were expected between healthy/young and aged/torn rotator cuff tissue. A total of 145 proteins were identified, but only 126 of these, with at least two identified peptides, were considered for the analysis. Panther classification system was used to sort proteins by compartments (see [Fig 1](#pone.0177656.g001){ref-type="fig"}). Out of the 126 proteins identified, 63 were extracellular matrix proteins, or proteins predominantly found in the extracellular region. This number is similar to a previous study of human patellar tendon, which has identified 166 proteins, but only 68 proteins with at least 2 peptides \[[@pone.0177656.ref018]\].

![The number of proteins in each cellular compartment of the proteome extracted from supraspinatus tendon samples using tryptic digestion.\
126 identified proteins (Progenesis, at least 2 identified peptides) were categorized using PANTHER classification system.](pone.0177656.g001){#pone.0177656.g001}

Extracellular proteins which were identified in trypsin-digested samples are summarised in [Table 2](#pone.0177656.t002){ref-type="table"}, and the accession number and number of peptides identified for each protein are given, as well as an indication if the protein was also identified in the elastase-digested samples. To give a simplified overview of the relative abundance of identified proteins (RA, see [Table 2](#pone.0177656.t002){ref-type="table"}), the mean percentage RA of each protein compared to COL1A1 was calculated for the control group. It should be noted that these ratios represent the relative abundance of these proteins in the trypsin-digested fraction of the normal tissue samples, and not an absolute value for supraspinatus tendon. Moreover, values were normalised to just one subunit of Collagen I, rather than total collagen content. As can be seen in [Table 2](#pone.0177656.t002){ref-type="table"}, five fibrillar collagens (I, II, III, V and XI) and three non-fibrillar collagens (VI, XV, XIV) were identified. The number of peptides identified for Collagen I and II was significantly higher than the average of around 90 previously reported (Sejersen et al. 2015). Among the non-fibrillar collagens, collagen VI was the most abundant, and also had a much higher number of peptide hits per subunit. In addition to collagens, 30 matricellular proteins were identified in the trypsin digested samples. These included three elastic fibre component proteins (fibrillin 1, fibrillin 2 and microfibillar associated protein 5), but not elastin, which was not detected in neither trypsin nor elastase digested samples. Seven members of the small leucine-rich proteoglycans (SLRPs) family were also identified and three of the thrombospondin family. The three most abundant matricellular proteins were cartilage oligomeric matrix protein (COMP), decorin, and fibrillin-1.

10.1371/journal.pone.0177656.t002

###### Identified collagens and matricellular proteins, showing accession number, name, peptide count and relative abundance (RA) as mean percentage of COL1A1 in young, healthy samples.

ES stands for elastase samples, and a (+) showing if proteins were identified in elastase digested samples. NQ is non-quantified, and (\*) is also known as microfibril-associated glycoprotein-2 (MAGP-2).
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  Classification           Family/Sub-group                                           Accession umber   Name                                     Protein symbol   Peptide count (unique)   Percentage of Col1A1 (RA)   ES
  ------------------------ ---------------------------------------------------------- ----------------- ---------------------------------------- ---------------- ------------------------ --------------------------- ----
  Collagens                Fibrillar collagens                                        P02452            Collagen alpha-1(I) COL1A1               230 (216)        100                      \+                          
  P08123                   Collagen alpha-2(I)                                        COL1A2            109 (103)                                53.47            \+                                                   
  P02458                   Collagen alpha-1(II)                                       COL2A1            17 (8)                                   0.05             \-                                                   
  P02461                   Collagen alpha-1(III)                                      COL3A1            138 (135)                                40.35            \+                                                   
  P20908                   Collagen alpha-1(V)                                        COL5A1            25 (20)                                  0.87             \+                                                   
  P05997                   Collagen alpha-2(V)                                        COL5A2            29 (26)                                  0.97             \+                                                   
  P12107                   Collagen alpha-1(XI)                                       COL11A1           6 (2)                                    0.08             \-                                                   
                           Non-fibrillar collagens                                    P12109            Collagen 1(VI)                           COL6A1           33 (29)                  1.56                        \+
  P12110                   Collagen 2(VI)                                             COL6A2            28 (24)                                  0.85             \+                                                   
  P12111                   Collagen 3(VI)                                             COL6A3            80 (75)                                  1.11             \+                                                   
  Q05707                   Collagen alpha-1(XIV)                                      COL14A1           16 (12)                                  0.005            \-                                                   
  P39059                   Collagen alpha-1(XV)                                       COL15A1           2 (2)                                    0.01             \+                                                   
  Matricellular proteins   Elastic fibre component                                    P35555            Fibrillin-1                              FBN1             46 (43)                  1.37                        \+
  P35556                   Fibrillin-2                                                FBN2              3 (0)                                    NQ               \-                                                   
  Q13361                   Microfibrillar-associated protein 5\*                      MFAP5             3 (3)                                    0.07             \-                                                   
  Q14767                   Latent-transforming growth factor beta-binding protein 2   LTBP2             4 (4)                                    0.03             \+                                                   
                           Small leucine-rich proteoglycans (SLRPs)                   P07585            Decorin                                  DCN              30 (28)                  4.13                        \+
  P20774                   Mimecan                                                    OGN               8 (7)                                    0.02             \-                                                   
  P51884                   Lumican                                                    LUM               17 (16)                                  0.5              \+                                                   
  Q06828                   Fibromodulin                                               FMOD              10 (10)                                  0.18             \+                                                   
  P21810                   Biglycan                                                   BGN               34 (31)                                  0.83             \+                                                   
  Q9BXN1                   Asporin                                                    ASPN              13 (13)                                  0.2              \-                                                   
  P51888                   Prolargin                                                  PRELP             20 (18)                                  0.55             \-                                                   
                           Lectican                                                   P13611            Versican core protein                    VCAN             21 (21)                  0.26                        \+
  P16112                   Aggrecan core protein                                      ACAN              11 (10)                                  0.008            \-                                                   
                           Tenascin                                                   P22105            Tenascin-X                               TNXB             72 (68)                  1.09                        \+
  P24821                   Tenascin                                                   TNC               10 (9)                                   0.01             \+                                                   
                           Fibulin                                                    P23142            Fibulin-1                                FBLN1            3 (3)                    0.02                        \-
                           Thrombo-spondins                                           P49747            Cartilage oligomeric matrix protein      COMP             43 (41)                  6.57                        \+
  P35443                   Thrombospondin-4                                           THBS4             10 (8)                                   0.08             \+                                                   
                           CILP                                                       O75339            Cartilage intermediate layer protein 1   CILP             28 (23)                  0.94                        \+
  Q8IUL8                   Cartilage intermediate layer protein 2                     CILP2             31 (26)                                  1.25             \+                                                   
                           Fibronectin type III domains                               Q7Z7G0            Target of Nesh-SH3                       ABI3BP           9 (8)                    0.06                        \-
  P02751                   Fibronectin                                                FN1               12 (12)                                  0.07             \+                                                   
                           Other                                                      Q15063            Periostin                                POSTN            10 (10)                  0.006                       \+
  P02765                   Alpha-2-HS-glycoprotein                                    AHSG              2 (2)                                    0.008            \-                                                   
  Q99972                   Myocilin                                                   MYOC              13 (13)                                  0.34             \-                                                   
  Q92954                   Proteoglycan 4 (Lubricin)                                  PRG4              5 (4)                                    0.01             \+                                                   
  P04004                   Vitronectin                                                VTN               2 (2)                                    0.02             \+                                                   
  P05452                   Tetranectin                                                CLEC3B            2 (2)                                    0.002            \+                                                   
  Q07507                   Dermatopontin                                              DPT               3 (3)                                    0.02             \-                                                   

[Table 3](#pone.0177656.t003){ref-type="table"} shows all collagens and matricellular proteins which varied significantly between torn and control tendon samples. There were no statistically significant differences of protein abundances between the torn samples from male and female groups. Collagens I and VI, but not III, were differentially abundant between control and torn samples. The ratio between collagen I and III, often used as a marker of tendon tissue repair, was not statistically different between healthy and torn samples, but the ratios between two of the three subunits of collagen VI (COL6A2 and COL6A3) were significantly different in healthy tendon ([Table 4](#pone.0177656.t004){ref-type="table"}). Ten matricellular proteins were statistically lower in torn samples (see [Table 3](#pone.0177656.t003){ref-type="table"}), and this reduction was observed in torn samples from both male and female donors. Proteins of interest are also presented individually below in Figs [2](#pone.0177656.g002){ref-type="fig"} and [3](#pone.0177656.g003){ref-type="fig"}, in order to demonstrate the spread of the data and ratios between the subunits and related proteins. In terms of variability, inter-patient variability can be seen by the spread of data points in Figs [2](#pone.0177656.g002){ref-type="fig"} and [3](#pone.0177656.g003){ref-type="fig"}. However, because a single and very small tissue sample was processed from each donor, any intra-patient variability is due to technical rather than biological variation. All proteins presented in [Table 3](#pone.0177656.t003){ref-type="table"} were significantly lower in torn samples compared to control. Overall, approximately 30% of the proteins detected were more abundant in torn samples compared to control, but only four of them significantly ([S1 Table](#pone.0177656.s002){ref-type="supplementary-material"}). None of the proteins upregulated in the torn samples was an extracellular compartment protein.

10.1371/journal.pone.0177656.t003

###### The ANOVA P value and mean fold change of differentially expressed extracellular proteins in the torn tissue of female and male patients compared to control in the trypsin digested samples.

(\*P \<0.05, \*\*P \<0.01, significantly different from control in post-test).
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  -----------------------------------------------------------
  Protein   ANOVA\    Mean fold change\   Mean fold change\
            P Value   F torn/Control      M torn/Control
  --------- --------- ------------------- -------------------
  COL1A1    0.0218    0.23\*              0.20\*

  COL1A2    0.0164    0.24\*              0.25\*

  COL6A1    0.0156    0.25\*              0.20\*

  COL6A2    0.0300    0.22\*              0.20\*

  FBN1      0.0175    0.08\*              0.22

  MFAP5     0.0301    0.16\*              0.26

  COMP      0.0021    0.06\*\*            0.07\*\*

  THBS4     0.0096    0.23\*              0.13\*

  CILP      0.0260    0.16\*              0.30

  CILP2     0.0095    0.08\*              0.06\*

  LTBP2     0.0136    0.08\*              0.13\*

  FBLN1     0.0074    0.19\*              0.13\*

  TNXB      0.0021    0.14\*\*            0.35\*

  MYOC      0.0157    0.11\*              0.22\*
  -----------------------------------------------------------

10.1371/journal.pone.0177656.t004

###### The ratios of COL3A1 to COL1A1, and of the subunits of Collagen I and Collagen VI in the three groups, Mean(SEM), \*P\<0.05 \*\*P\<0.01 significantly different from control.
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                    Control         Female torn         Male torn
  ----------------- --------------- ------------------- -----------------
  COL3A1 : COL1A1   0.502 (0.076)   0.583 (0.068)       0.66 (0.062)
  COL1A1 : COL1A2   1.745 (0.065)   1.699 (0.044)       1.511 (0.079)\*
  COL6A1:COL6A2     2.243 (0.29)    1.786 (0.277)       1.722 (0.184)
  COL6A3:COL6A2     1.675 (0.231)   3.309 (0.529)\*\*   2.944 (0.215)\*

![The relative abundance of collagens and their subunits in supraspinatus tendon from control and pathologic female and male donors.\
Dot plots show biological replicates, means and standard error of the mean. (A) COL1A1, (B) COL1A2, (C) COL3A1, (D), COL5A1, (E) COL5A2, (F) COL6A1, (G) COL6A2, (H) COL6A3 and (I) COL14A1. (J) Floating bars showing minimum and maximum relative abundance of the subunits of collagen I with a line at the mean and (K) the relative abundance of the subunits of collagen VI. (L) The ratio of collagen III to I, average of ratios in individual runs within each group (duplicates per sample, n = 18 per group). \*P\<0.05, \*\*P\<0.01 significantly different from control.](pone.0177656.g002){#pone.0177656.g002}

![The relative abundance of differentially expressed elastic fibre components (A-D) and members of the thrombospondin family associated proteins (E-G).\
Dot plots show biological replicates, means and standard error of the mean. (A) fibrillin-1 (FBN1), (B) microfibrillar associated protein 5 (MFAP5), (C) Fibulin-1 (FBLN1), (D) Latent-transforming growth factor beta-binding protein 2 (LTBP2), (E) Thrombospondin-1, (F) Thrombospondin 4, and (G) cartilage oligomeric protein (COMP). (H) Western blot of COMP (around 100kDa), confirming higher prevalence in control compared to female and male torn and aged tendon samples. \*P\<0.05, \*\*P\<0.01 significantly different from control.](pone.0177656.g003){#pone.0177656.g003}

Of the ten matricellular proteins significantly lower in torn samples (listed in [Table 3](#pone.0177656.t003){ref-type="table"}), four are strongly linked to elastic fibres (see [Fig 3A--3D](#pone.0177656.g003){ref-type="fig"}). Of these four, three are elastic fibre components (FBN1, MFAP5, and LTBP2), and one is known to be associated with elastic fibres (FBLN1) \[[@pone.0177656.ref019], [@pone.0177656.ref020]\]. A significant lower abundance of LTBP2 in torn and aged samples was also identified in the elastase-digested samples ([Table 5](#pone.0177656.t005){ref-type="table"}). FBLN2, another elastic fibre component previously reported in canine tendons \[[@pone.0177656.ref021]\] was identified but was not quantified because of a low peptide count. Of the three members of the thrombospondin family identified here, two (COMP and THBS4) were statistically lower in torn tendons compared to control ([Fig 3F and 3G](#pone.0177656.g003){ref-type="fig"}). Among the matricellular proteins, cartilage oligomeric matrix protein (COMP) was reduced with the highest probability (ANOVA P = 0.0021, adjusted for multiple comparisons: 0.0052 and 0.0057 for female and male, respectively). This reduced abundance was further validated using western blot ([Fig 3H](#pone.0177656.g003){ref-type="fig"}) and in the elastase-digested samples ([Table 5](#pone.0177656.t005){ref-type="table"}).

10.1371/journal.pone.0177656.t005

###### The mean relative abundance of differentially expressed extracellular proteins in the elastase digested samples, mean (SEM), (\*P\<0.05 \*\*P\<0.01 significantly different from control).
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  ----------------------------------------------------------------------
  Protein   Peptide count\   ANOVA\    Fold change\     Fold change\
            (unique)         P Value   F torn/Control   M torn/Control
  --------- ---------------- --------- ---------------- ----------------
  COMP      48 (36)          0.0236    0.09\*           0.11\*

  CILP      29 (26)          0.0258    0.15\*           0.16\*

  CILP2     32 (29)          0.0209    0.11\*           0.04\*

  LTBP2     6 (6)            0.0178    0.25\*           0.34\*

  TNXB      26 (25)          0.0022    0.25\*\*         0.23\*\*
  ----------------------------------------------------------------------

Elastase digestion {#sec009}
------------------

Since many ECM proteins contain sequences lacking lysine and arginine residues and are therefore refractory to trypsin mediated proteolysis, we utilized elastase to complement and expand the tendon proteome. In total, 79 proteins were identified in the elastase-digested samples (with at least two peptide hits), much lower than the 126 proteins identified in the tryptic digestion batch. 29% of the proteins identified were unique (see [S2 Table](#pone.0177656.s003){ref-type="supplementary-material"}), whereas 71% overlapped with the trypsin-digested samples. The extracellular compartment predictably dominated the elastase-digested proteome, and overall the distribution of identified proteins in the different cellular compartment was very similar to trypsin-digested proteome ([Fig 4](#pone.0177656.g004){ref-type="fig"}). One major discrepancy between the proteomes of the trypsin and elastase digestions was the inverted abundance ratio of the collagen I subunits (COL1A1 and COL1A2), as well as a much lower number of unique peptides identified for COL1A1 (70 unique peptides in elastase digested samples and 216 in trypsin digested samples). The ratios between the subunits of collagen VI were also fairly different, although there was an increase in the ratio of COL6A3:COL6A2 in torn samples (see [S3 Table](#pone.0177656.s004){ref-type="supplementary-material"}), similar to the trend observed in trypsin digested samples. The abundances of none of the collagen superfamily were significantly different between the torn and control groups. Five matricellular proteins (COMP, CILP1, CILP2, LTBP2 and TNXB, see [Table 5](#pone.0177656.t005){ref-type="table"}) had a significantly lower abundance in torn samples, similarly to the trypsin-digested samples. Interestingly, and despite using elastase for its specific ability to digest elastin, no elastin peptides were identified in any of the 27 samples analysed. To ensure that the absence of elastin was not due to an error in the protocol, rat aorta was digested as a control using the same protocol, and elastin was detected with a protein score of 2093 and 57% coverage (see [S1 Appendix](#pone.0177656.s001){ref-type="supplementary-material"}). Taken together, and unless there were some solubility issues specific to elastin in this tissue, these findings suggest that elastin is not as highly abundant in human supraspinatus tendon as previously suggested for tendon in general \[[@pone.0177656.ref002]\]. Other proteins highly relevant to tendon development and disease were only identified in the elastase digested samples, including Cadherin 11 (CDH11), an important tendon development cell-surface marker, and hydrocephalus-inducing protein homolog (HYDIN), which was statistically lower in torn samples, and has been previously linked to cilia dysfunction related diseases. A full list of proteins uniquely identified in the elastase-digested samples is in [S2 Table](#pone.0177656.s003){ref-type="supplementary-material"}.

![The number of hits in each cellular compartment in samples digested by either trypsin (blue) or elastase (orange).\
Identified proteins (Progenesis, 2 or more peptides) were categorized using PANTHER classification system. Although tryspin digestion yielded more hits, there was a similar distribution of proteins in the compartments.](pone.0177656.g004){#pone.0177656.g004}

Discussion {#sec010}
==========

This study is the first inventory of the proteome of human supraspinatus tendon ECM from young, healthy patients and an older cohort of patients with rotator cuff tears. A major advantage of this study is the use of elastase digestion in parallel to trypsin, providing an interesting comparison and a non-targeted validation. The findings presented here provide a confirmation of significant changes to at least five proteins already studied in ageing and injured tendon tissue, as shown in [Table 6](#pone.0177656.t006){ref-type="table"}.

10.1371/journal.pone.0177656.t006

###### Previously published studies confirming the disruption of COL1, COL6, FBN1, COMP and LTBP2 in torn and/or aged tendons.
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  ------------------------------------------------------------------------------------------------------------------------------
  Protein   Findings from previous studies
  --------- --------------------------------------------------------------------------------------------------------------------
  COL1      Highly organised collagen matrix is replaced by aberrant collage in human RC \[[@pone.0177656.ref022]\]\
            Degenerate human supraspinatus and subscapularis tendons had a reduced collagen content \[[@pone.0177656.ref023]\]

  COL6      Type VI collagen transcription was upregulated in human rotator cuff tears \[[@pone.0177656.ref005]\]

  FBN1      Fibrillin 1 transcription was upregulated in human rotator cuff tears \[[@pone.0177656.ref005]\]

  COMP      Equine tendon COMP is reduced with age \[[@pone.0177656.ref026]\]\
            Specific cleavage patterns of COMP in injured horse tendon \[[@pone.0177656.ref025]\]

  LTBP2     TGF-beta superfamily members were dysregulated in diseased compared to healthy tendons \[[@pone.0177656.ref011]\]
  ------------------------------------------------------------------------------------------------------------------------------

A clear downregulation of collagens has been previously described in torn supraspinatus tendon \[[@pone.0177656.ref022]--[@pone.0177656.ref024]\] and in particular a significant reduction in the abundance of both of the subunits of collagen I. Moreover, a significantly lower abundance of cartilage oligomeric matrix protein (COMP) was measured in torn samples. COMP was the most abundant matricellular protein detected in this study, and its reduced abundance was also observed in the elastase digested samples and by western blot. A similar reduction of COMP in injured tendon has been previously reported in the horse superficial digital flexor tendon \[[@pone.0177656.ref025]\]. It is also known that COMP levels fall with age \[[@pone.0177656.ref026]\]. As COMP is known to co-localise with collagen I \[[@pone.0177656.ref027]\], this quantitative analysis supports the assumption that the torn tendons in older patients have suffered a significant degradation of collagen I fibrils. Surprisingly, no significant change of collagen III was measured. Indeed, there was a non-significant increase in the ratio of collagen I and collagen III, in line with previous findings from total collagen measurements in cadaver supraspinatus \[[@pone.0177656.ref023]\], but overall the abundance of collagen III was slightly lower (although not significantly) in the older, torn samples. This is an interesting issue, and a recent systematic review of the literature has made a claim that the expression of collagen III is increased in tendinopathy \[[@pone.0177656.ref012]\]. Although this claim is well supported by transcriptome data \[[@pone.0177656.ref028]--[@pone.0177656.ref031]\], protein evaluation directly from torn supraspinatus has resulted in mixed results, with one study showing an increase in the ratio of collagen III to collagen I \[[@pone.0177656.ref023]\] and another a reduction in both collagens \[[@pone.0177656.ref024]\]. This calls for some consideration of the possibly significant differences between transcriptome and proteome data, with processes such as degradation or the presence of complex post-transcriptional regulation pathways affecting the actual composition of the tissue. Additionally, a recent detailed study of collagen distribution in the supraspinatus tendon has shown that the content of collagen III is homogeneously distributed, and not specifically localised in regions where tears are known to initiate \[[@pone.0177656.ref032]\]. Thus, it is possible that the previously observed increase in the relative abundance of collagen III is the result of a more pronounced decrease in collagen I, as we observed in our quantitative analysis, although further work is required to ascertain this point.

At least four proteins associated with elastic fibres were significantly less abundant in the torn and aged samples: fibrillin-1 (FBN1), microfibrillar associated protein 5 (MFAP5), Fibulin-1 (FBLN1), and Latent-transforming growth factor beta-binding protein 2 (LTBP2). No elastin has been detected in any samples, neither in the trypsin nor the elastase digested tissue, and its absence in the latter requires further investigation and explanation. The large glycoprotein FBN1 was the third most abundant matricellular protein identified in this study, consistent with its role as the main structural component of beaded microfibrils. It is known to interact directly with MAFP5 \[[@pone.0177656.ref033], [@pone.0177656.ref034]\], as well as LTBP2, with the latter targeting and sequestering TGF-*β* to the fibrillin-microfibril niche, as well as binding fibulins \[[@pone.0177656.ref035]\]. FBLN1 has been shown to co-localise with elastic fibres, but there is little information about its exact role \[[@pone.0177656.ref020], [@pone.0177656.ref036]\] The existence of fibillin-rich microfibrils in tendon has previously been described in fetal calf achilles \[[@pone.0177656.ref033]\], canine flexor digitorum profundus \[[@pone.0177656.ref037]\], bovine flexor tendon \[[@pone.0177656.ref003]\], and in human supraspinatus tendons, where they have been shown to be regularly distributed and in the vicinity of tendon cell arrays \[[@pone.0177656.ref005]\], with all these studies showing elastin to co-localise with the fibrillin microfibers. It is curious, therefore, in light of the high abundance of fibrillin-1 detected here and the use of elastase digestion as validation, that we did not detect any elastin peptides. There is a possibility that elastin in supraspinatus tendon is cross-linked or modified in a manner which renders it difficult to extract or insoluble. However, one theory worth exploring is that fibrillin-microfibrils in supraspinatus tendon are elastin-free, similarly to the ones described in the periodontal ligament \[[@pone.0177656.ref038]\]. An in situ hybridization study of the localised expression of ECM components in healing supraspinatus tendon in the rat has found elastin to be present only in blood vessels \[[@pone.0177656.ref039]\], and a recent study in the horse superficial digital flexor tendon has shown elastin was predominantly localised to the interfascicular matrix \[[@pone.0177656.ref040]\], whilst it is well established that fibrillin-rich microfibrils are regularly interspersed throughout the fascicular matrix. Regardless of the absence of elastin, the observation that four different elastic fibre components were significantly less abundant in torn tendons, suggests a systematic damage to the fibrillin-rich microfibril niche. This is supported by a previous study, which observed a disturbance to fibrillin-rich elastic fibres in large and massive supraspinatus tears using confocal microscopy \[[@pone.0177656.ref005]\]. The impairment of this micro-environment, which serves as a repository for growth factors, and in particular TGF-*β* \[[@pone.0177656.ref035]\], may also help to explain the disruption of the TGF-*β* axis in tendinopathy \[[@pone.0177656.ref011]\]. In light of the important role of the fibrillin-rich microfiber in tendon, not just as a structural component of the ECM, but as a network of cell and matrix interactions with considerable effects on cell function \[[@pone.0177656.ref041]\], it will be of interest to resolve the question of its exact composition in the supraspinatus tendon. The clear and direct interaction of this niche with collagen fibrils and the pericellular region is demonstrated in [Fig 5](#pone.0177656.g005){ref-type="fig"}.

![The interactions of all proteins which were significantly reduced in torn samples compared to control, created using the STRING database.\
The different line colours represent the different types of associations between the differentially modulated proteins, which include known interactions such as those identified in the curated database (light blue), and experimentally determined (purple). Other interactions identified were via text mining (green), co-expression (black) and protein homology (grey). Proteins are: COL1A1, Collagen 1(I); COL1A2, Collagen 2(I); COL6A1, Collagen 1(VI); COL6A2, Collagen 2(VI); FBLN1, Fibrillin-1; MFAP5, microfibrillar associated protein 5; COMP, Cartilage oligomeric protein; THSD4, Thrombospondin-4; CILP1, Cartilage intermediate layer protein 1; CILP2, Cartilage intermediate layer protein 2; TGFB1, Latent-transforming growth factor beta-binding protein 2; FBN1, Fibulin-1; TNXB, Tenascin-X; MYOC, Myocilin.](pone.0177656.g005){#pone.0177656.g005}

In terms of the pericellular region, at least two proteins localised at this niche were altered in aged, torn tendon: collagen VI and thrombspondin-4 (THBS4) \[[@pone.0177656.ref042], [@pone.0177656.ref043]\]. Collagen VI is a non-fibrillar collagen known to form highly branched, beaded filamentous networks which encircles collagen fibrils and is particularly abundant in the pericellular region around cell arrays in several tissues, including muscle and tendon \[[@pone.0177656.ref021], [@pone.0177656.ref044]\]. It is composed of three different peptide chains COL6A1 and COL6A2 and COL6A3, the latter much larger and thought to be responsible for the intracellular assembly of the subunits \[[@pone.0177656.ref045]\]. In this study a statistically significant reduction in the abundance of subunits COL6A1 and COL6A2, and a significant change to the ratios of the subunits between the young and older, torn tendons was found. This differential expression of the subunits has been shown before in vitro, with COL6A1 and COL6A2 but not COL6A3 upregulated in the presence of three- dimensional collagen I gel \[[@pone.0177656.ref046]\]. Interestingly, whilst the reduction in collagen VI in torn, aged tendon observed here is in accordance with a recent proteome study in a horse model \[[@pone.0177656.ref047]\], it is contrast with previous transcription results from our laboratory, which has shown collagen VI to be upregulated in rotator cuff tears \[[@pone.0177656.ref005]\], indicating yet again the gap between the transcriptome and the proteome. Nevertheless, these significant changes add weight to recent evidence of the importance of the pericellular region, and specifically collagen VI, in tendon matrix assembly and repair \[[@pone.0177656.ref048], [@pone.0177656.ref049]\].

To summarise other findings, two members of the cartilage intermediate layer protein (CILP) family were identified: CILP1 and CILP2, and both had significantly lower abundance in the aged, torn tendon groups. Proteomics studies have previously identified CILP in horse SDFT \[[@pone.0177656.ref025]\] as well as human patellar tendon \[[@pone.0177656.ref018]\], but its localisation and function has not been studied to date. Given the important role of small leucine rich proteoglycans (SLRPs) in tendon development, it was surprising that none of the seven members of the family identified here were significantly modified in the torn tendon samples. Moreover, unlike a previous proteome study demonstrating significant differences in collagens and SLRPs between male and female patellar tendon proteome \[[@pone.0177656.ref018]\], we did not find any significant gender differences, although admittedly the male and female cohorts compared were both from patients with a rotator cuff tear, and thus not representative of normal, healthy supraspinatus.

Several limitations of the study should be acknowledged. Control samples used for this study were supraspinatus biopsies from patients undergoing shoulder stabilisation. Whilst it was ensured that no macroscopic injury was visible, we cannot eliminate the possibility of microscopic damage to tendon fibres during the biopsy process, leading to changes in protein levels. Moreover, because the torn comparison group was significantly older than the control, some of the differences observed may be due to ageing rather than disease. This is a common problem in studies involving human tissue, where tissue from aged but healthy patients is difficult to collect. Several limitation may arise from the use of ultrasound-guided tissue sampling, including the absence of direct inspection of the tendon and the sampling site, which may lead to a sampling error. However, these limitations are largely offset by enabling a much larger number of donors. Although the small size of the biopsy resulted in relatively few cellular proteins, a good quality extraction of the extracellular compartment was achieved, but another limitation is the insoluble nature of collagen in ageing human tendons \[[@pone.0177656.ref023]\]. Despite using a harsh and lengthy digestion protocol, it is expected that the digestion of the highly cross-linked collagen I was incomplete, and as evidence to this issue, the ratio of collagen III:I was at least one fold higher than previously reported. Moreover, there remains a risk of a less consistent and incomplete digestion compared with young tendon tissue.

The use of elastase digestion as a validation also carries several limitations. Elastase is an enzyme with a broad specificity and digestion of proteins with this enzyme leads to the generation of overlapping peptides (unlike trypsin, which has a very tight specificity and produces identical, non-overlapping peptides from a protein). For this reason, quantitation of protein expression differences is generally performed using trypsin, as evident throughout the literature. Particularly in this dataset, with highly modified proteins, the trypsin data is the one to be considered more reliable. However, as can be seen from our results, the elastase digestion did provide useful information about additional proteins (see see [S2 Table](#pone.0177656.s003){ref-type="supplementary-material"}), as well as confirmed the differential abundance of several major ECM proteins.

Conclusions {#sec011}
===========

To conclude, these findings confirm measurable degradation of collagen fibrils and associated proteins in torn supraspinatus tendons, suggesting that a significant loss of organised tendon tissue is associated with tendon disease and ageing. A marked reduction of COMP strengthen the possibility of using this glycoprotein and its peptides as a marker for tendon injury, as previously suggested in a horse model. The inventory also suggests that elastin is not a major component of human supraspinatus tendon, although more evidence is required to confirm this. Finally, we identified a severe modulation of the elastic fibre, fibrillin-rich niche and the pericellular matrix, suggesting further investigation of these structures could help to explain the cellular processes associated with tendon ageing and tendinopathy.
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###### MAscot search results for elastin (ELN) in elastase digested rat aorta.

Using the same elastase digestion protocol used on human tendon, elastin was identified in rat aorta with good confidence and sequence coverage.

(PDF)

###### 

Click here for additional data file.

###### The mean fold change of proteins of all compartments which were upregulated in the torn, trypsin digested samples.

(\*P\<0.05 \*\*P\<0.01 significantly different from control in post-test).

(TIF)

###### 

Click here for additional data file.

###### Proteins identified uniquely in the elastase digested samples and their ANOVA p value.

(The arrows indicate if the proteins were downregulated (↓) or upregulated (↑) in the torn samples.).

(TIF)

###### 

Click here for additional data file.

###### The ratios of collagen III to I and of the subunits of collagen I, (COL1A1 and COL1A2) and collagen VI (COL6A1, COL6A2 and COL6A3) in the elastase digested samples.

(mean ± SEM, \*P\<0.05 significantly different from control).

(TIF)

###### 

Click here for additional data file.

This work was supported by the NIHR (MSK Biomedical Research Unit)

[^1]: **Competing Interests:**The authors have declared that no competing interests exist.

[^2]: **Conceptualization:** OH NT.**Data curation:** OH NT.**Formal analysis:** OH NT.**Funding acquisition:** AC BK.**Investigation:** OH NT RM AC.**Methodology:** OH NT BK.**Project administration:** OH.**Resources:** OH NT RM BK AC.**Software:** OH NT.**Validation:** OH NT.**Visualization:** OH.**Writing -- original draft:** OH.**Writing -- review & editing:** OH NT BK.

[^3]: Current address: Department of Genetics and Molecular Biology, Federal University of the state of Rio de Janeiro, Rio de Janeiro, Brazil
